Research ArticleOriginal Article
Open Access

Clinical characteristics and in-hospital mortality of COVID-19 adult patients in Saudi Arabia

Samah I. Abohamr, Rami M. Abazid, Mubarak A. Aldossari, Hala A. Amer, Omar S. Badhawi, Obaid M. Aljunaidi, Shaimaa H. Alzarzour, Hiba M. Saadeddin, Fayaz A. Bhat and Eman Elsheikh
Saudi Medical Journal November 2020, 41 (11) 1217-1226; DOI: https://doi.org/10.15537/smj.2020.11.25495

References

  1. ↵
    1. Song W,
    2. Gui M,
    3. Wang X,
    4. Xiang Y
    (2018) Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog 14:e1007236.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Wu Y,
    2. Chen C,
    3. Chan Y
    (2020) The outbreak of COVID-19:An overview. J Chin Med Assoc 83:217–20.
    OpenUrlCrossRefPubMed
    1. Cucinotta D,
    2. Vanelli M
    (2020) WHO declares COVID-19 a pandemic. Acta Biomed 91:157–160.
    OpenUrlPubMed
  4. ↵
    1. Sohrabi C,
    2. Alsafi Z,
    3. O'Neill N,
    4. Khan M,
    5. Kerwan A,
    6. Al-Jabir A,
    7. et al.
    (2020) World Health Organization declares global emergency:A review of the 2019 novel coronavirus (COVID-19). Int J Surg 76:71–76.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Perlman S
    (2020) Another Decade, another coronavirus. N Engl J Med 382:760–762.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Haleem A,
    2. Javaid M,
    3. Vaishya R,
    4. Deshmukh SG
    (2020) Areas of academic research with the impact of COVID-19. Am J Emerg Med 38:1524–1526.
    OpenUrlPubMed
  7. ↵
    1. Petrosillo N,
    2. Viceconte G,
    3. Ergonul O,
    4. Ippolito G,
    5. Petersen E
    (2020) COVID-19, SARS and MERS:are they closely related? Clin Microbiol Infect 26:729–734.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Xu X,
    2. Chen P,
    3. Wang J,
    4. Feng J,
    5. Zhou H,
    6. Li X,
    7. et al.
    (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63:457–460.
    OpenUrlCrossRefPubMed
  9. ↵
    1. REUTERS
    Saudi Arabia announces first case of coronavirus, Updated 2020 March 2, Available form URL: https://www. reuters.com/article/us-health-coronavirus-saudi/saudi-arabia-announcesfirst-case-of-coronavirus-idUSKBN20P2FK. Accessed 2020 August.
  10. ↵
    1. Yang J,
    2. Zheng Y,
    3. Gou X,
    4. Pu K,
    5. Chen Z,
    6. Guo Q,
    7. et al.
    (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2:a systematic review and meta-analysis. Int J Infect Dis 94:91–95.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Chen T,
    2. Wu D,
    3. Chen H,
    4. Yan W,
    5. Yang D,
    6. Chen G,
    7. et al.
    (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091.
    OpenUrlAbstract/FREE Full Text
    1. Arentz M,
    2. Yim E,
    3. Klaff L,
    4. Lokhandwala S,
    5. Riedo F,
    6. Chong M,
    7. et al.
    (2020) Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA 323:1612–1614.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y,
    7. et al.
    (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Guan W,
    2. Ni Z,
    3. Hu Y,
    4. Liang W,
    5. Ou C,
    6. He J,
    7. et al.
    (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 382:1708–1720.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Huang X,
    2. Wei F,
    3. Hu L,
    4. Wen L,
    5. Chen K
    (2020) Epidemiology and clinical characteristics of COVID-19. Arch Iran Med 23:268–271.
    OpenUrl
  16. ↵
    1. Saudi Center for Disease Prevention Control, Ministry of Health Saudi Novel Corona Virus (2019-nCoV) Infection Guidelines V1.0
    , Update January 2020, Available from URL: https://www.moh.gov.sa/en/CCC/healthp/regulations/Documents/Novel%20Corona%20Virus%20Infection%20Guidelines.pdf. Accessed 2020 August.
  17. ↵
    1. Tian S,
    2. Hu N,
    3. Lou J,
    4. Chen K,
    5. Kang X,
    6. Xiang Z,
    7. et al.
    (2020) Characteristics of COVID-19 infection in Beijing. J Infect 80:401–406.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Zhu W,
    2. Xie K,
    3. Lu H,
    4. Xu L,
    5. Zhou S,
    6. Fang S
    (2020) Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei China. J Med Virol 92:1525–1532.
    OpenUrlPubMed
  19. ↵
    1. Chen N,
    2. Zhou M,
    3. Dong X,
    4. Qu J,
    5. Gong F,
    6. Han Y,
    7. et al.
    (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study. Lancet 395:507–513.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Oudit GY,
    2. Pfeffer MA
    (2020) Plasma angiotensin-converting enzyme 2:novel biomarker in heart failure with implications for COVID-19. Eur Heart J 41:1818–1820.
    OpenUrl
  21. ↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z,
    7. et al.
    (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China:a retrospective cohort study. Lancet 395:1054–1062.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Richardson S,
    2. Hirsch JS,
    3. Narasimhan M,
    4. Crawford JM,
    5. McGinn T,
    6. Davidson KW,
    7. et al.
    (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 323:2052–2059.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Kulcsar KA,
    2. Coleman CM,
    3. Beck SE,
    4. Frieman MB
    (2019) Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight 4:e131774.
    OpenUrl
  24. ↵
    1. Maddaloni E,
    2. Buzzetti R
    (2020) Covid-19, and diabetes mellitus:unveiling the interaction of two pandemics. Diabetes Metab Res Rev, e33213321.
  25. ↵
    1. Sun P,
    2. Qie S,
    3. Liu Z,
    4. Ren J,
    5. Li K,
    6. Xi J
    (2020) Clinical characteristics of hospitalized patients with SARS-CoV-2 infection:A single arm meta-analysis. J Med Virol 92:612–617.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Rodriguez-Morales AJ,
    2. Cardona-Ospina JA,
    3. Gutiérrez-Ocampo E,
    4. Villamizar-Peña R,
    5. Holguin-Rivera Y,
    6. Escalera-Antezana JP,
    7. et al.
    (2020) Clinical, laboratory and imaging features of COVID-19:A systematic review and meta-analysis. Travel Med Infect Dis 34:101623.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Pan L,
    2. Mu M,
    3. Yang P,
    4. Sun Y,
    5. Wang R,
    6. Yan J,
    7. et al.
    (2020) Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China. Am J Gastroenterol 115:766–773.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Aghagoli G,
    2. Gallo Marin B,
    3. Soliman LB,
    4. Sellke FW
    (2020) Cardiac involvement in COVID-19 patients:Risk factors, predictors, and complications:A review. J Card Surg 35:1302–1305.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Lippi G,
    2. Plebani M
    (2020) Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 58:1131–1134.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Fried JA,
    2. Ramasubbu K,
    3. Bhatt R,
    4. Topkara VK,
    5. Clerkin KJ,
    6. Horn E,
    7. et al.
    (2020) The variety of cardiovascular presentations of COVID-19. Circulation 141:1930–1936.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Wang Y,
    2. Lu X,
    3. Li Y,
    4. Chen H,
    5. Chen T,
    6. Su N,
    7. et al.
    (2020) Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med 201:1430–1434.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Guan WJ,
    2. Liang WH,
    3. Zhao Y,
    4. Liang HR,
    5. Chen ZS,
    6. Li YM,
    7. et al.
    (2020) Comorbidity and its impact on 1590 patients with COVID-19 in China:a nationwide analysis. Eur Respir J 55:2000547.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Zaim S,
    2. Chong JH,
    3. Sankaranarayanan V,
    4. Harky A
    (2020) COVID-19 and multiorgan response. Curr Probl Cardiol 45:100618.
    OpenUrlCrossRefPubMed
  34. ↵
    1. MacLaren G,
    2. Fisher D,
    3. Brodie D
    (2020) Preparing for the most critically ill patients with COVID-19:The potential role of extracorporeal membrane oxygenation. JAMA 323:1245–1246.
    OpenUrl
  35. ↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J,
    7. et al.
    (2020) Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061–1069.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Zhang G,
    2. Hu C,
    3. Luo L,
    4. Fang F,
    5. Chen Y,
    6. Li J,
    7. et al.
    (2020) Clinical features, and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 127:104364.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Ruan Q,
    2. Yang K,
    3. Wang W,
    4. Jiang L,
    5. Song J
    (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 05(46):846–848.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords